3IP
UTHR icon

3Chopt Investment Partners’s United Therapeutics UTHR Stock Holding History

3Chopt Investment Partners’s Portfolio UTHR Stock Details UTHR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-708
Closed -$218K – 248
2025
Q1 		$218K Buy
+708
New +$243K 0.06% 199

Other funds holding UTHR

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
LSV Asset Management
LSV Asset Management Chicago, Illinois $46.4B AUM 27.74% 1-Year Est. Return

3Chopt Investment Partners's UTHR Position: Q2 2025 in Review

3Chopt Investment Partners sold out of United Therapeutics (UTHR) in Q2 2025, closing a stake of 708 shares — an estimated $218K sold.

3Chopt Investment Partners first reported a position in UTHR in Q1 2025 and held it in 1 quarter. The position peaked at $218K in Q1 2025. 670 funds tracked by Wall St. Rank hold UTHR as of Q2 2025.

  • 3Chopt Investment Partners reported no remaining United Therapeutics position as of Q2 2025 after selling out during the quarter.
  • 3Chopt Investment Partners sold 708 United Therapeutics shares in Q2 2025, an estimated $218K.
  • 3Chopt Investment Partners first reported a position in United Therapeutics in Q1 2025 and held it in 1 quarter.
  • 3Chopt Investment Partners's United Therapeutics position peaked at $218K in Q1 2025.
  • 670 funds tracked by Wall St. Rank held United Therapeutics as of Q2 2025.

Based on 3Chopt Investment Partners's 13F filing for Q2 2025, filed 24 Jul 2025.